Literature DB >> 21220422

Phosphomimetic mutations enhance oligomerization of phospholemman and modulate its interaction with the Na/K-ATPase.

Qiujing Song1, Sandeep Pallikkuth, Julie Bossuyt, Donald M Bers, Seth L Robia.   

Abstract

Na/K-ATPase (NKA) activity is dynamically regulated by an inhibitory interaction with a small transmembrane protein, phospholemman (PLM). Inhibition is relieved upon PLM phosphorylation. Phosphorylation may alter how PLM interacts with NKA and/or itself, but details of these interactions are unknown. To address this, we quantified FRET between PLM and its regulatory target NKA in live cells. Phosphorylation of PLM was mimicked by mutation S63E (PKC site), S68E (PKA/PKC site), or S63E/S68E. The dependence of FRET on protein expression in live cells yielded information about the structure and binding affinity of the PLM-NKA regulatory complex. PLM phosphomimetic mutations altered the quaternary structure of the regulatory complex and reduced the apparent affinity of the PLM-NKA interaction. The latter effect was likely due to increased oligomerization of PLM phosphomimetic mutants, as suggested by PLM-PLM FRET measurements. Distance constraints obtained by FRET suggest that phosphomimetic mutations slightly alter the oligomer quaternary conformation. Photon-counting histogram measurements revealed that the major PLM oligomeric species is a tetramer. We conclude that phosphorylation of PLM increases its oligomerization into tetramers, decreases its binding to NKA, and alters the structures of both the tetramer and NKA regulatory complex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220422      PMCID: PMC3059012          DOI: 10.1074/jbc.M110.198036

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells.

Authors:  Eileen M Kelly; Zhanjia Hou; Julie Bossuyt; Donald M Bers; Seth L Robia
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

Review 2.  Structures of the FXYD regulatory proteins in lipid micelles and membranes.

Authors:  Carla M Franzin; Xiao-Min Gong; Peter Teriete; Francesca M Marassi
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

3.  Crystal structure of the sodium-potassium pump at 2.4 A resolution.

Authors:  Takehiro Shinoda; Haruo Ogawa; Flemming Cornelius; Chikashi Toyoshima
Journal:  Nature       Date:  2009-05-21       Impact factor: 49.962

4.  Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex.

Authors:  Zhanjia Hou; Eileen M Kelly; Seth L Robia
Journal:  J Biol Chem       Date:  2008-08-16       Impact factor: 5.157

5.  FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C.

Authors:  William Fuller; Jacqueline Howie; Linda M McLatchie; Roberta J Weber; C James Hastie; Kerry Burness; Davor Pavlovic; Michael J Shattock
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-01       Impact factor: 4.249

Review 6.  Mechanistic studies of sodium pump.

Authors:  Larry D Faller
Journal:  Arch Biochem Biophys       Date:  2008-06-17       Impact factor: 4.013

7.  Phospholemman-mediated activation of Na/K-ATPase limits [Na]i and inotropic state during beta-adrenergic stimulation in mouse ventricular myocytes.

Authors:  Sanda Despa; Amy L Tucker; Donald M Bers
Journal:  Circulation       Date:  2008-03-24       Impact factor: 29.690

8.  Solid-state 17O NMR spectroscopy of a phospholemman transmembrane domain protein: implications for the limits of detecting dilute 17O sites in biomaterials.

Authors:  Alan Wong; Andrew J Beevers; Andreas Kukol; Ray Dupree; Mark E Smith
Journal:  Solid State Nucl Magn Reson       Date:  2008-04-11       Impact factor: 2.293

9.  Phospholemman transmembrane structure reveals potential interactions with Na+/K+-ATPase.

Authors:  Andrew J Beevers; Andreas Kukol
Journal:  J Biol Chem       Date:  2007-08-13       Impact factor: 5.157

Review 10.  Phospholemman: its role in normal cardiac physiology and potential as a druggable target in disease.

Authors:  Michael J Shattock
Journal:  Curr Opin Pharmacol       Date:  2009-02-03       Impact factor: 5.547

View more
  18 in total

1.  Phospholamban binds with differential affinity to calcium pump conformers.

Authors:  Philip Bidwell; Daniel J Blackwell; Zhanjia Hou; Aleksey V Zima; Seth L Robia
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

2.  Residues 248-252 and 300-304 of the cardiac Na+/Ca2+ exchanger are involved in its regulation by phospholemman.

Authors:  Xue-Qian Zhang; JuFang Wang; Jianliang Song; Angi M Ji; Tung O Chan; Joseph Y Cheung
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-06       Impact factor: 4.249

3.  Oligomeric interactions of sarcolipin and the Ca-ATPase.

Authors:  Joseph M Autry; John E Rubin; Sean D Pietrini; Deborah L Winters; Seth L Robia; David D Thomas
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

4.  Cardiac Calcium ATPase Dimerization Measured by Cross-Linking and Fluorescence Energy Transfer.

Authors:  Daniel J Blackwell; Taylor J Zak; Seth L Robia
Journal:  Biophys J       Date:  2016-09-20       Impact factor: 4.033

5.  ATP-Binding Cassette Transporter Structure Changes Detected by Intramolecular Fluorescence Energy Transfer for High-Throughput Screening.

Authors:  Surtaj H Iram; Simon J Gruber; Olga N Raguimova; David D Thomas; Seth L Robia
Journal:  Mol Pharmacol       Date:  2015-04-29       Impact factor: 4.436

6.  Evolutionary patterns of phosphorylated serines.

Authors:  Yerbol Z Kurmangaliyev; Alexander Goland; Mikhail S Gelfand
Journal:  Biol Direct       Date:  2011-02-09       Impact factor: 4.540

7.  L30A Mutation of Phospholemman Mimics Effects of Cardiac Glycosides in Isolated Cardiomyocytes.

Authors:  Ryan D Himes; Nikolai Smolin; Andreas Kukol; Julie Bossuyt; Donald M Bers; Seth L Robia
Journal:  Biochemistry       Date:  2016-10-25       Impact factor: 3.162

8.  Na⁺/K⁺-ATPase E960 and phospholemman F28 are critical for their functional interaction.

Authors:  Mounir Khafaga; Julie Bossuyt; Luiza Mamikonian; Joseph C Li; Linda L Lee; Vladimir Yarov-Yarovoy; Sanda Despa; Donald M Bers
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

9.  The inhibitory effect of phospholemman on the sodium pump requires its palmitoylation.

Authors:  Lindsay B Tulloch; Jacqueline Howie; Krzysztof J Wypijewski; Catherine R Wilson; William G Bernard; Michael J Shattock; William Fuller
Journal:  J Biol Chem       Date:  2011-08-25       Impact factor: 5.157

10.  A separate pool of cardiac phospholemman that does not regulate or associate with the sodium pump: multimers of phospholemman in ventricular muscle.

Authors:  Krzysztof J Wypijewski; Jacqueline Howie; Louise Reilly; Lindsay B Tulloch; Karen L Aughton; Linda M McLatchie; Michael J Shattock; Sarah C Calaghan; William Fuller
Journal:  J Biol Chem       Date:  2013-03-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.